Metraipolis › archive › dc_141e6980288e
Allergen immunotherapy for the control of moderate to severe allergic asthma: an evidence-based conjoint analysis to define candidate patient profiles in… — Europe PMC PMID:41246131
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41246131
- DOI
- 10.3389/falgy.2025.1676399
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T22:52:32.535Z
- SHA-256 of the archived text
88e3ccaec411d8b1bbbc05a9a4f1392d2178a4b825c464a108f45cf6b92a54bf- Stable URL of this page
https://metraipolis.com/documento/dc_141e6980288e
How to cite
Allergen immunotherapy for the control of moderate to severe allergic asthma: an evidence-based conjoint analysis to define candidate patient profiles in… — Europe PMC PMID:41246131 — Europe PMC (en), https://europepmc.org/article/MED/41246131 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_141e6980288e (Metraipolis archive dc_141e6980288e, sha256 88e3ccaec411d8b1bbbc05a9a4f1392d2178a4b825c464a108f45cf6b92a54bf)
BibTeX
@misc{dc141e6980288e,
title = {Allergen immunotherapy for the control of moderate to severe allergic asthma: an evidence-based conjoint analysis to define candidate patient profiles in… — Europe PMC PMID:41246131},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41246131},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_141e6980288e; sha256 88e3ccaec411d8b1bbbc05a9a4f1392d2178a4b825c464a108f45cf6b92a54bf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41246131. Agents can read the archived copy with the MCP tool read_document.